Lexology January 4, 2023
As the industry readies itself for the January 2023 pilgrimage to the J.P. Morgan Healthcare Conference (JPM) and Biotech Showcase in San Francisco, our market-leading life sciences and health care industry team has prepared a series of updates that we hope will help strategically guide your 2023 partnering and investment decisions.
Caution remains a strong theme in the current market. But caution should not lead to paralysis. Now more than ever, companies must think strategically and be more nimble about attracting investments and/or strategic partnerships and defining their pathways to regulatory approval and product commercialization.
Digital therapeutics (DTx) have incredible promise, but because they are in many ways revolutionary, they struggled to fit within existing frameworks for delivering care. Here...
Today's Sponsors
Today's Sponsor